IDEX CORP /DE/ Quarterly Liabilities and Equity in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Idex Corp /De/ quarterly Liabilities and Equity history and growth rate from Q2 2010 to Q2 2024.
  • Idex Corp /De/ Liabilities and Equity for the quarter ending June 30, 2024 was $5.9B, a 3.21% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.9B +$183M +3.21% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $5.89B +$231M +4.09% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $5.87B +$353M +6.41% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $5.67B +$777M +15.9% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $5.72B +$807M +16.4% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $5.66B +$658M +13.2% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $5.51B +$595M +12.1% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $4.89B +$38M +0.78% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $4.91B +$130M +2.71% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $5B +$539M +12.1% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 $4.92B +$503M +11.4% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $4.85B +$629M +14.9% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $4.78B +$709M +17.4% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $4.46B +$517M +13.1% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $4.41B +$600M +15.7% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $4.23B +$512M +13.8% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $4.07B +$433M +11.9% Jun 30, 2020 10-Q 2020-07-24
Q1 2020 $3.94B +$392M +11% Mar 31, 2020 10-Q 2020-04-24
Q4 2019 $3.81B +$340M +9.79% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.71B +$159M +4.48% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $3.64B +$157M +4.5% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $3.55B +$66M +1.89% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $3.47B +$74.2M +2.18% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $3.55B +$237M +7.15% Sep 30, 2018 10-Q 2018-10-24
Q2 2018 $3.48B +$259M +8.04% Jun 30, 2018 10-Q 2018-07-25
Q1 2018 $3.49B +$322M +10.2% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 $3.4B +$245M +7.76% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $3.32B +$55.3M +1.7% Sep 30, 2017 10-Q 2017-10-23
Q2 2017 $3.22B +$115M +3.69% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $3.16B +$21.5M +0.68% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $3.15B +$350M +12.5% Dec 31, 2016 10-K 2018-02-22
Q3 2016 $3.26B +$392M +13.7% Sep 30, 2016 10-Q 2016-10-25
Q2 2016 $3.11B +$206M +7.1% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $3.14B +$273M +9.52% Mar 31, 2016 10-Q 2016-04-25
Q4 2015 $2.81B -$98M -3.38% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $2.87B -$69M -2.35% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $2.9B -$87.6M -2.93% Jun 30, 2015 10-Q 2015-07-27
Q1 2015 $2.87B -$82.7M -2.8% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $2.9B +$15.9M +0.55% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $2.94B +$89.9M +3.16% Sep 30, 2014 10-Q 2014-10-27
Q2 2014 $2.99B +$163M +5.78% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 $2.95B +$129M +4.58% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $2.89B +$102M +3.67% Dec 31, 2013 10-K 2015-02-23
Q3 2013 $2.85B -$108M -3.65% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 $2.83B -$29.2M -1.02% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 $2.82B -$56.5M -1.96% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $2.79B -$50.7M -1.79% Dec 31, 2012 10-K 2014-02-13
Q3 2012 $2.96B +$63.7M +2.2% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $2.86B -$66.5M -2.28% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $2.88B +$414M +16.8% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $2.84B +$454M +19.1% Dec 31, 2011 10-K 2013-02-21
Q3 2011 $2.89B +$547M +23.3% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $2.92B +$712M +32.2% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $2.47B Mar 31, 2011 10-Q 2011-05-03
Q4 2010 $2.38B Dec 31, 2010 10-K 2012-02-24
Q3 2010 $2.35B Sep 30, 2010 10-Q 2010-11-04
Q2 2010 $2.21B Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.